Dialysis Clinical Outcomes Revisited (DCOR) Trial

Completed · Phase 4

Conditions studied: Chronic Kidney Disease

In brief

This is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients. Informed consent will be obtained and the inclusion/exclusion criteria reviewed. Eligible patients will be randomized to receive either Renagel or a calcium-based binder. Starting from the randomization date, mortality data including survival, death date and cause of death (vital status information) and morbidity data including hospitalization date will be recorded for all patients. These data will be collected until the end of the study (December 31, 2004, ± 2 weeks). Patients completing or terminating from the study will return to the phosphate binder prescribed by their usual healthcare provider.

Key facts

Study ID

NCT00324571

Run by

Genzyme, a Sanofi Company

People needed

2000

Starts

2001-03-01

Expected to finish

2006-02-01

Last updated by the study team

2015-03-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients must be 18 years of age or older,
• on dialysis for more than 3 months,
• require phosphate binder therapy,
• have Medicare as their primary insurance.

You may not qualify if…

• dysphagia,
• swallowing disorders,
• severe gastrointestinal motility disorders,
• bowel obstruction.

Where it is running

• nTouch Research — Huntsville, Alabama, United States
• Kidney Health Institute, LLC — Tucson, Arizona, United States
• Gambro Healthcare — El Cerrito, California, United States
• Palomar Medical Group — Escondido, California, United States
• Gambro Healthcare-Los Angeles — Los Angeles, California, United States
• Balboa Nephrology Medical Group — San Diego, California, United States
• Nephrology Educational Services and Research — Tarzana, California, United States
• Lowry Dialysis Center — Denver, Colorado, United States
• Nephrology Associates, P.C. — Bridgeport, Connecticut, United States
• Gambro Healthcare-Hartford — Hartford, Connecticut, United States
• Nephrology Associates — New Britain, Connecticut, United States
• InterAmerican Dialysis — Coral Gables, Florida, United States
• DaVita Crystal River Dialysis — Crystal River, Florida, United States
• Gambro Healthcare-Miami — Miami, Florida, United States
• Miami Kidney Group — Miami, Florida, United States
• Pensacola Nephrology, P.A. — Pensacola, Florida, United States
• Gambro Healthcare-Plantation — Plantation, Florida, United States
• America Dialysis — St. Petersburg, Florida, United States
• Genesis Clinical Research Corp — Tampa, Florida, United States
• Gambro Healthcare-Americus — Americus, Georgia, United States
• nTouch Research — Atlanta, Georgia, United States
• Gambro Healthcare-Douglas — Douglas, Georgia, United States
• Gambro Healthcare-Douglasville — Douglasville, Georgia, United States
• Dublin Nephrology — Dublin, Georgia, United States
• Gambro Healthcare-Gadsden — Gadsden, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.